Emergent BioSolutions Inc. (EBS)
NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 7.63 |
| 開市 | 7.56 |
| 買盤 | 7.75 x 800 |
| 賣出價 | 7.89 x 800 |
| 今日波幅 | 7.62 - 8.19 |
| 52 週波幅 | 1.42 - 15.10 |
| 成交量 | |
| 平均成交量 | 3,168,816 |
| 市值 | 416.375M |
| Beta 值 (5 年，每月) | 1.59 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -11.22 |
| 業績公佈日 | 2024年11月06日 - 2024年11月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.00 |
ZacksEBS Stock Rises on FDA Nod for ACAM2000 in Mpox Indication
The FDA approves Emergent BioSolutions' sBLA seeking a label expansion of ACAM2000 for the mpox indication. Stock rises in pre-market trading.
Barrons.comEmergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine
Shares of Emergent BioSolutions were charging higher after the vaccine maker announced the Food and Drug Administration approved its smallpox vaccine for Mpox disease in individuals at high risk for infection. Emergent stock was up 8.6% to $9.68 in trading Friday. Earlier this month, the World Health Organization declared the Mpox outbreak a public-health emergency of international concern.
Investor's Business DailyThis Biotech Stock Surges As WHO Health Emergency Stirs FDA Approval
The FDA approved a supplemental application to expand Emergent BioSolutions' existing smallpox vaccine to include Mpox.
